Diagnosis of acute Lyme neuroborreliosis Since 2005, the chemotactic cytokine (chemokine) CXCL13 has been considered a potential biomarker for acute Lyme neuroborreliosis [1, 2]. Lyme neuroborreliosis is the neurological manifestation of tick-borne Lyme disease which is caused by the spirochete Borrelia burgdorferi sensu lato and frequently occurs in the northern hemisphere. Symptomes of Lyme neuroborreliosis include inflammation of the central nervous system […]